Is INO a buy? - Seeking Alpha

Quote & Headlines Market Currents StockTalk

Today 5d 1m 3m 1y 5y 10y

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

2,282 people get INO articles and Market Currents by email alert.

Get email alerts on INO »

FOCUS | PRO | RELATED | TRANSCRIPTS | NEWS & PR

Inovio Pharmaceuticals: 2 100% Results In 2 Months
Healthcare Specialist • Fri, Jun 14 • 13 Comments
Sorting Out Inovio Claims
William Meyers • Wed, Jun 12 • 6 Comments
Why You Should Be Investing In DNA Vaccination Technology And Inovio Pharmaceuticals
Healthcare Specialist • Thu, May 16 • 23 Comments
Inovio Pharmaceuticals: Why Best Therapeutic Vaccine Award In 2013?
Iggy Igette • Tue, May 14 • 22 Comments
Inovio's Hepatitis C Data: What Does It Really Mean?
EnhydrisPECorp • Fri, Apr 5 • 45 Comments
Advaxis Vs. Inovio: A Head To Head Comparison Of 2 Cervical Cancer Vaccines
EnhydrisPECorp • Thu, Feb 21 • 21 Comments
Any More Gas Left In Inovio's Tank After Recent Rally?
Brian L. Wilson • Wed, Feb 6 • 11 Comments
Flu Season Highlights Demand For Comprehensive Vaccines
Cris Frangold • Thu, Jan 31 • 1 Comment
This Could Be The Coming Out Year For Inovio Pharmaceuticals
Smith On Stocks • Tue, Jan 22 • 11 Comments
Inovio Pharmaceuticals: The Risks Outweigh The Rewards
EnhydrisPECorp • Mon, Jan 21 • 24 Comments
Why It Is Reasonable For Inovio To Be $2
BuySellShort • Tue, Nov 27, 2012 • 27 Comments
Investing In Cervical Cancer: Merck, Glaxo, And... Inovio?
Nouvelle Asset Management • Tue, Oct 9, 2012 • 14 Comments
Inovio Biomedical's Innovative Approach to DNA Vaccine Delivery
Mike Havrilla • Fri, Dec 14, 2007
Inovio’s Delivery Technology Boosts Cancer Vaccine Potency
Sara Calabro • Thu, May 24, 2007
Inovio Biomedical: Shocking Tumor Technology Tempting to Big Pharmas
Andrew Vaino • Mon, Feb 26, 2007

To learn more about Seeking Alpha Pro, click here.

A Comprehensive Overview Of Active Electroporation Cancer Trials
Suresh Gupta • Tue, May 14 • 18 Comments
Speculative Bio Stocks For Investors
Stock Investor • Wed, May 8 • 4 Comments
Imminent Catalysts For Small Pharmaceuticals
Chemistfrog • Tue, May 7 • 9 Comments
Different Threats, Different Solutions, Many Ways To Make Money
Daniel Lauchheimer • Thu, May 2 • 14 Comments
A Tale Of Three Pharmaceuticals: Getting Exciting In 2013
Chemistfrog • Mon, Apr 29 • 18 Comments
3 Microcap Biopharma Plays For The H7N9 Influenza Outbreak
Healthcare Specialist • Tue, Apr 16 • 18 Comments
Stock Watch Thursday, 11 April 2013
VFC's Stock House • Thu, Apr 11 • 8 Comments
Minimizing Risk When Investing In Biopharmas
Healthcare Specialist • Wed, Apr 10 • 17 Comments
Tech And Healthcare: Eye Catching Themes Of Early April
D. Mero • Tue, Apr 9 • 17 Comments
3 Biotechs With Recent Intensive Insider Buying
Markus Aarnio • Sun, Apr 7 • 13 Comments
3 Biopharmas With Significant Potential
Healthcare Specialist • Thu, Apr 4 • 21 Comments
2 Cancer Stocks Ready To Rally
BuySellShort • Thu, Mar 21 • 21 Comments
A Quick Look At 8 Biotechs Ready To Gain Momentum
Craig Keolanui • Mon, Mar 11 • 10 Comments
Looking Back To Alternative Cancer Therapies
Dutch Trader • Mon, Mar 11
A Comprehensive Look At Immunotherapy - Part 2
Brian Nichols • Mon, Mar 4 • 24 Comments
Will The Flu Vaccine Race Send Novartis Higher?
IncomeHunter • Thu, Feb 7 • 4 Comments
Small Pharmaceuticals With Near Term Catalysts - Durect And Inovio
BuySellShort • Mon, Feb 4 • 11 Comments
3 Small-Cap Biotechs With Zero Debt And Sustainable Revenue
Matt Schilling • Thu, Jan 31 • 3 Comments
Weekly Stock Watch, Week Of 22 January, 2013
VFC's Stock House • Tue, Jan 22
Stock Watch Tuesday, 15 January
VFC's Stock House • Tue, Jan 15 • 11 Comments

There are no Transcripts on INO.

Inovio's Universal H7N9 DNA Vaccine Generates First Protective Antibody Responses Against Virulent H7N9 Virus in 100% of Vaccinated Animals

PR Newswire (Fri, 4:00AM)
Inovio Pharmaceuticals DNA Vaccine Against Ebola and Marburg Filoviruses Provides Complete Protection in Preclinical Challenge Study

PR Newswire (May 14, 2013)
Inovio Pharmaceuticals Reports 2013 First Quarter Financial Results

PR Newswire (May 10, 2013)
Inovio Pharmaceuticals Universal H1N1 Influenza Vaccine Achieves Protective Immune Responses Comparable to Conventional Vaccine in Phase I Study

PR Newswire (Apr 18, 2013)
Inovio Pharmaceuticals Recognized With "Best Therapeutic Vaccine" and "Best Early Stage Biotech" Awards at World Vaccine Congress 2013

PR Newswire (Apr 18, 2013)
Inovio Pharmaceuticals & U.S. Army Receive $3.5 Million Biodefense Grant to Further Develop Mass Vaccination Device

PR Newswire (Apr 10, 2013)
Inovio Collaborator ChronTech Reports Interim Phase II Clinical Study Results from ChronVac-C Vaccine for Hepatitis C Infection

PR Newswire (Apr 2, 2013)
Inovio Pharmaceuticals to Present at BioCentury's "Future Leaders in the Biotech Industry" Conference

PR Newswire (Mar 28, 2013)
Inovio Pharmaceuticals Reports 2012 Fourth Quarter and Year End Financial Results

PR Newswire (Mar 18, 2013)
Inovio Pharmaceuticals Closes $15.1 Million Offering of Common Stock and Warrants

PR Newswire (Mar 12, 2013)
Inovio Pharmaceuticals Prices $15.1 Million Offering of Common Stock and Warrants

PR Newswire (Mar 7, 2013)
Inovio Pharmaceuticals to Present at the Cowen & Company Health Care Conference

PR Newswire (Feb 27, 2013)
Inovio Pharmaceuticals, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com

PR Newswire (Feb 11, 2013)
Inovio Pharmaceuticals, Inc. to Webcast, Live, at RetailInvestorConferences.com on February 7th

PR Newswire (Feb 5, 2013)
Inovio Pharmaceuticals to Present at BIO CEO & Investor Conference

PR Newswire (Feb 4, 2013)
After-Hours Buzz: INTC, AXP & More

at CNBC.com (Jan 17, 2013)
Inovio Pharmaceuticals to Initiate Clinical Trial for its Hepatitis C Therapeutic Vaccine (INO-8000) Later this Year

PR Newswire (Jan 9, 2013)
PATH Malaria Vaccine Initiative and Inovio Pharmaceuticals Partner to Accelerate Development of Malaria Vaccines and Innovative Delivery Technologies

PR Newswire (Jan 7, 2013)
Inovio Pharmaceuticals to Present at Biotech Showcase 2013 Investor Conference

PR Newswire (Dec 20, 2012)
Inovio's Synthetic Flu Vaccine Doubles Rate of Elderly Subjects Displaying Protective Immune Responses

PR Newswire (Dec 10, 2012)

INO vs. ETF Alternatives

Company Description

Currently, there's no company description for INO.

Sector: Healthcare

Industry: Biotechnology

Country: United States

All
| Earnings
| Dividends
| M&A
| On the move

Friday, June 14, 7:39 AM Shares of Inovio (INO) rise 16.13% premarket as the company's H7N9 (Avian Flu) vaccine produces a protective antibody response in 100% of animals vaccinated. The HAI titer was 1:130 versus the 1:40 required to demonstrate protection in humans. (PR) 2 Comments [Healthcare]
Tuesday, May 14, 9:42 AM Inovio Pharmaceuticals (INO +6.6%) pops after saying its SynCon DNA vaccine for the Marburg and Ebola viruses provides 100% protection against death. (PR) 1 Comment [Healthcare, On the Move]
Friday, May 10, 4:48 PM Inovio (INO): Q1 EPS of -$0.06 misses by $0.02. Revenue of $1.5M beats by $0.49M. (PR) 2 Comments [Earnings, Breaking News, Healthcare]
Thursday, April 18, 1:34 PM Inovio Pharmaceuticals (INO +0.4%) says Phase 1 studies of its SynCon universal H1N1 influenza vaccine generated protective antibody levels comparable to a current FDA-approved seasonal influenza vaccine against a currently circulating influenza strain. INO adds that this is the first demonstration of a SynCon influenza vaccine achieving a protective immune response rate comparable to a conventional seasonal vaccine for a circulating influenza strain. 1 Comment [Healthcare]
Tuesday, April 2, 8:36 AM Inovio (INO) plummets 13.3% after saying that a Phase II trial that tested the use of the company's MedPulser delivery device in conjunction with ChronTech's ChronVac vaccine for hepatitis C failed to show "a statistically significant difference" between the vaccinated and non-vaccinated groups. (PR) Comment! [On the Move, Healthcare]
Tuesday, March 19, 6:36 AM Inovio Pharmaceuticals (INO): Q4 EPS of $0.00. Revenue of $1.1M. (PR) Comment! [Earnings, Breaking News, Healthcare]
Thursday, March 7, 8:20 AM Inovio Pharmaceuticals (INO) plummets 20.3% to $0.55 after pricing an offering of 27.4M shares, and warrants to purchase up to 13.69M shares, at a combined price of $0.55/share and related warrant. The warrants are exercisable at $0.7936/share and will expire in 5 1/2 years. The net proceeds of the fundraising are $14M. (PR) 2 Comments [Healthcare, On the Move]
Friday, January 18, 11:25 AM Inovio Pharmaceuticals (INO +2.8%) bucks a lackluster tape to trade higher after Piper Jaffray initiates coverage with an Overweight. Piper notes the company is developing a novel DNA-based vaccine platform that is demonstrating "provocative" immune responses in early studies against a multiplicity of non-viral oncology targets, as well as several infectious diseases such as HIV, HCV, HPV, and the flu. The firm adds that multiple Phase II catalysts are expected this year in its HCV and leukemia platforms. Comment! [Healthcare, On the Move]
Friday, January 18, 9:17 AM Geron (GERN) +5.4% after an upgrade to Buy with $3 price target by Piper Jaffray's Charles Duncan. The current price of $1.66 reflects past challenges, he says, but leaves room for substantial upside over the course of the next year. That Geron and INO are buys at Piper while ZIOT and THLD are Holds does not compute, says Dan Rosenblum. Sell-side games, says TheStreet's Adam Feuerstein. 1 Comment [Healthcare, On the Move]
Wednesday, October 10, 2012, 3:46 PM Inovio Pharmaceuticals (INO +14.8%) pops after announcing Phase I clinical results indicating that its DNA-based synthetic vaccine VGX-3100 is not only capable of boosting immune responses to antigens from high risk types of human papillomavirus infection, but also killing cells changed by the virus into precancerous dysplasias. Comment! [Healthcare, On the Move]
Tuesday, January 31, 2012, 7:59 AM Shares of Inovio Pharmaceuticals (INO) shoot 23.2% higher in premarket trading after the firm announces that it moved close to a "universal" influenza vaccine after animal studies of its treatment showed positive immune responses and data. The company expects to report human data on the vaccine by the end of Q1. Comment! [Healthcare, On the Move]
Tuesday, September 13, 2011, 1:08 PM Inovio Pharmaceuticals (INO +7.3%) says early data from a Phase I study assessing its PENNVAX-G global HIV vaccine demonstrated "strong immune responses and safety." Comment! [Healthcare, On the Move]
Thursday, July 14, 2011, 9:41 AM Inovio Pharmaceuticals (INO +2.7%) gains at the open after announcing Phase I tests on T cell and antibody responses were successful in its clinical study of VGX-3400X, a vaccine to prevent avian H5N1 influenza. Comment! [Healthcare, On the Move]
Tuesday, July 5, 2011, 8:00 AM Inovio Pharmaceuticals (INO) shoots up 12.3% premarket after announcing its synthetic DNA vaccine protects against HIV in animal testing. Comment! [Healthcare, On the Move]
Monday, May 9, 2011, 9:00 AM Premarket gainers: INO +13%. DTG +9%. BSFT +8%. AFFX +7%. ALKS +6%. EXK +5%. GPL +5%. SYY +5%. ELN +4%. HL +4%. SQNM +3%. CEF +3%. SD +3%.
Losers: ZSL -11%. ZRAN -10%. GKK -8%. IRE -3%. LEXG -3%. Comment! [On the Move]
Monday, February 7, 2011, 9:00 AM Premarket gainers: PDE +17%. BEC +10%. PGNX +9%. INO +5%. GLUU +5%. OREX +5%. DHR +5%. EMKR +4%. MGIC +4%. CHK +4%. AIB +4%.
Losers: YONG -10%. WY -5%. SYY -4%. Comment!

Gtg007
$INO looks Good, with good pipeline of potential drugs..Might Go LONG soon..any opinions?
May 23, 4:02 PM
Reply (6)

• !Report Abuse
View all 6 replies
workhorse@bps: Just be prepared to hold for along time, I plan to cover when the price is double what i bought, but then hold for the lonnnnnnng haul
May 30, 2:31 PM
• !Report Abuse
Gtg007: Ok workhorse will hold for long time...i am thinking it will double in next few months..but i will hold for as much time as possible.Thanks!
May 30, 5:01 PM
• !Report Abuse
Add a reply...

140 characters

smokeyRose
All my stocks are Doing well except $CBO $INO (which I am going to Dump, can't take the pain anymore with That one) $ICON while up still
Apr 30, 3:00 PM
Reply (1)

• !Report Abuse
View all 1 replies
smokeyRose: for me a little in the Red. Good Pick is $CTCM Which is doing Nicely for me.
Apr 30, 3:01 PM
• !Report Abuse
Add a reply...

140 characters

Chemistfrog
$INO traded down due to poor data from collaborator using their own DNA. Updates on the company using their own DNA could really push it up
Apr 20, 7:33 PM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

VFC's Stock House
$SSH, $INO, $APHY.OB Stock Watch Wednesday, http://bit.ly/cAHZ42 - $SNWV.OB, $ANTB.OB, $TTNP.OB
Apr 11, 8:56 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

tomfalbo
guna b a gud ME for $APPA.OB, $INO, $TSRX
Mar 19, 8:51 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

TruffelPig
Just bought some $INO AH and got a discount......0.52. Weird. Was the only trade. Closed at 0.54.
Mar 8, 5:48 PM
Reply (3)

• !Report Abuse
View all 3 replies
Noreika: Do you believe the CEO is really blind to the results of the studies like he says he is?
Mar 8, 7:24 PM
• !Report Abuse
TruffelPig: I really don't know. They have a nice pipeline - I know that.
Mar 8, 7:49 PM
• !Report Abuse
Add a reply...

140 characters

TruffelPig
Fute stars in biotech: http://bit.ly/W9bQXv $ECYT $THLD $INO of mine are there. (INO as of tomorrow)
Mar 7, 8:57 PM
Reply (1)

• !Report Abuse
View all 1 replies
TruffelPig: Future.......
Mar 7, 9:36 PM
• !Report Abuse
Add a reply...

140 characters

Everywhereman
$INO owns part of the drug chrontech is testing, ino has no holdi gs in the company
Feb 14, 11:41 AM
Reply (2)

• !Report Abuse
View all 2 replies
Kyle_Ramer: Everywhereman -you seem a little confused to the original constructs of the deal the initial deal
Mar 5, 1:12 PM
• !Report Abuse
Everywhereman: Perhaps. But then I am in good company as that is what INO management says. May I inquire as to your source?
Mar 6, 11:23 PM
• !Report Abuse
Add a reply...

140 characters

BioInvestor2013
$INO INOVIO can acquire ChronTech with only 1% of ChronTech outstanding shares !! This is Great !!
Feb 9, 1:16 PM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

BioInvestor2013
$INO owns 50% of ChronTech !! Kim mentioned that Inovio owns half of Chronvac-C and full rights to Electroporation of the drug !!
Feb 9, 1:15 PM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

LATEST REPLIES

Gtg007
$INO looks Good, with good pipeline of potential drugs..Might Go LONG soon..any opinions?
May 23, 4:02 PM
Reply (6)

• !Report Abuse
View all 6 replies
workhorse@bps: Just be prepared to hold for along time, I plan to cover when the price is double what i bought, but then hold for the lonnnnnnng haul
May 30, 2:31 PM
• !Report Abuse
Gtg007: Ok workhorse will hold for long time...i am thinking it will double in next few months..but i will hold for as much time as possible.Thanks!
May 30, 5:01 PM
• !Report Abuse
Add a reply...

140 characters

smokeyRose
All my stocks are Doing well except $CBO $INO (which I am going to Dump, can't take the pain anymore with That one) $ICON while up still
Apr 30, 3:00 PM
Reply (1)

• !Report Abuse
View all 1 replies
smokeyRose: for me a little in the Red. Good Pick is $CTCM Which is doing Nicely for me.
Apr 30, 3:01 PM
• !Report Abuse
Add a reply...

140 characters

TruffelPig
Just bought some $INO AH and got a discount......0.52. Weird. Was the only trade. Closed at 0.54.
Mar 8, 5:48 PM
Reply (3)

• !Report Abuse
View all 3 replies
Noreika: Do you believe the CEO is really blind to the results of the studies like he says he is?
Mar 8, 7:24 PM
• !Report Abuse
TruffelPig: I really don't know. They have a nice pipeline - I know that.
Mar 8, 7:49 PM
• !Report Abuse
Add a reply...

140 characters

TruffelPig
Fute stars in biotech: http://bit.ly/W9bQXv $ECYT $THLD $INO of mine are there. (INO as of tomorrow)
Mar 7, 8:57 PM
Reply (1)

• !Report Abuse
View all 1 replies
TruffelPig: Future.......
Mar 7, 9:36 PM
• !Report Abuse
Add a reply...

140 characters

Everywhereman
$INO owns part of the drug chrontech is testing, ino has no holdi gs in the company
Feb 14, 11:41 AM
Reply (2)

• !Report Abuse
View all 2 replies
Kyle_Ramer: Everywhereman -you seem a little confused to the original constructs of the deal the initial deal
Mar 5, 1:12 PM
• !Report Abuse
Everywhereman: Perhaps. But then I am in good company as that is what INO management says. May I inquire as to your source?
Mar 6, 11:23 PM
• !Report Abuse
Add a reply...

140 characters

BioInvestor2013
$INO easy a. 250 Million Market Cap !!
Feb 7, 5:22 AM
Reply (1)

• !Report Abuse
View all 1 replies
workhorse@bps: Here is hoping and I agree, there are a lot of other companies with smaller pipelines and same stage that have larger mrkt cap
Feb 7, 9:27 AM
• !Report Abuse
Add a reply...

140 characters

smokeyRose
Wow have u seen the Bump in $INO good keep Going!
Jan 17, 12:25 PM
Reply (4)

• !Report Abuse
View all 4 replies
smokeyRose: he he
Jan 17, 1:32 PM
• !Report Abuse
Everywhereman: Does anyone know of a specific catalyst today?
Feb 5, 2:29 PM
• !Report Abuse
Add a reply...

140 characters

VFC's Stock House
Stock Watch Wednesday - $AA, $BA, $FCEL, $D, $INO, $DNDN, $PBTH, $TEVA, $MRIC.OB http://bit.ly/cAHZ42
Jan 9, 12:37 PM
Reply (4)

• !Report Abuse
View all 4 replies
VFC's Stock House: Haha, SmokeyRose - I don't know much more than anyone else, except that $INO is up about twenty five percent this year. Nice. Good luck!
Jan 9, 2:13 PM
• !Report Abuse
smokeyRose: thanks! i'm staying with it.
Jan 10, 1:38 PM
• !Report Abuse
Add a reply...

140 characters

VFC's Stock House
$INO Moving higher...http://bit.ly/Xh5qUw
Jan 8, 8:00 AM
Reply (7)

• !Report Abuse
View all 7 replies
VFC's Stock House: ..put more into any individual investment to where you lose sleep at night. some here, some there...just my opinion.
Jan 8, 8:34 AM
• !Report Abuse
Noreika: Good advice, thanks again.
Jan 8, 9:48 AM
• !Report Abuse
Add a reply...

140 characters

iadops40
INO...and why not be up +20% !?!?!
11/12/12
Reply (5)

• !Report Abuse
View all 5 replies
iadops40: added 2nd position INO friday @ 0.55 1/2
11/12/12
• !Report Abuse
Avoc: The recent drop in INO stockprice is due to a huge fund selling most of their holdings in order to get some money, perhaps due to taxes.
11/22/12
• !Report Abuse
Add a reply...

140 characters

smokeyRose
INO
10/22/12
Reply (2)

• !Report Abuse
View all 2 replies
jtank: INO seems like an overlooked biotech company with potential, granted its gonna take a few months-years but it's worth the risk in my opinion
10/22/12
• !Report Abuse
smokeyRose: Like Meatloaf says..... "You took the words Right out of my Mouth"
10/24/12
• !Report Abuse
Add a reply...

140 characters

VFC's Stock House
Weekly Stock Watch ... $DNDN, $CPST, $ONCS.OB, $AEZS, $INO, $GE, $BAC ... more ... http://bit.ly/R6JcSY
10/15/12
Reply (1)

• !Report Abuse
View all 1 replies
GVT: Any news on $IMSC ?
10/17/12
• !Report Abuse
Add a reply...

140 characters

iadops40
INO looking really good here, deep pipeline http://bit.ly/TmcOwm, and Phase I results for VGX-3100 released today. bullish!
10/10/12
Reply (1)

• !Report Abuse
View all 1 replies
iadops40: http://bit.ly/RxNRfQ
10/10/12
• !Report Abuse
Add a reply...

140 characters

VFC's Stock House
Weekly Stock Watch - $BBRY, $CPST, $DNDN, $SGYP, $INO, $ONTY, $ONCS.OB, $AEZS, $FCEL - http://bit.ly/SX8eSw
9/30/12
Reply (1)

• !Report Abuse
View all 1 replies
NEInvPro: News today on SSH.
10/1/12
• !Report Abuse
Add a reply...

140 characters

TruffelPig
My INO buy seems timely. Buying more right now!
9/10/12
Reply (3)

• !Report Abuse
View all 3 replies
TruffelPig: Yes, lol, better late than never I guess :)
9/10/12
• !Report Abuse
joe kelly: Interesting. I don;t follow you closely but you do seem to have a good track record TruffelPig. Might get some more ino myself now.
9/18/12
• !Report Abuse
Add a reply...

140 characters

INO Inovio Pharmaceuticals, Inc.

INO

Inovio Pharmaceuticals, Inc.